Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations Carolina Delgado Martínez; Mariano Gómez-Rubio; Cecilia Gómez-Domínguez;

Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs Caiyun Yang; Fengxiang Lv; Jiaqi Yang; Dawei Ding; Lina Cui; Ying Han;

Nomogram for prediction of long-term survival with hepatocellular carcinoma based on NK cell counts Lihua Yu; Xiaoli Liu; Xinhui Wang; Dongdong Zhou; Huiwen Yan; Yuqing Xie; Qing Pu; Ke Zhang; Zhiyun Yang;